| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bf0bb8b07e151d4bcead749d7dd699 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 |
| filingDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb12fd17dd543dbd159b1d81b1db041a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9632fca9372246f7a3a8bc5bd67fdc36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6250c7e50b873433c70458434dbba7b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eebcc0f340ec59a3a155b52c16a197eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a034bf6130b17e3305bc801f9957fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d203295094dfb0ac7e067c4a15c56d60 |
| publicationDate |
2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019016188-A1 |
| titleOfInvention |
IMMUNOGENIC COMPOSITION |
| abstract |
The invention relates to synthetic (eg recombinant) pneumococcal saccharides comprising one or more repeat units → 4) -β-D-Glc p - (1 → 4) - [Gro- (2 → P → 3)] - β- D-Gal p - (1 → 4) -β-L-Rha p - (1 → The invention also relates to conjugates comprising a → 4) -β-D-Glc p - (1 → 4) - [ Gro- (2 → P → 3)] - β-D-Gal p - (1 → 4) -β-L-Rha p - (1 →, immunogenic compositions, vaccines and their use in prevention or treatment infection with Streptococcus pneumoniae . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022007326-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020249737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491216-B2 |
| priorityDate |
2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |